Nissan Chemical Corporation and Sanwa Kagaku Kenkyusho Co., Ltd., two Japanese companies, have announced they recently co-created an antisense oligonucleotide (ASO) for DRPLA. ASOs have emerged as a promising strategy for various neurodegenerative conditions,...
Junko Shiozawa, Advisory Board Member to CureDRPLA, has created a community of Japanese families affected by DRPLA. They offer peer support to each other and host online meetings. Since DRPLA is more common in Japan, it was important for us to create a Japanese...
CureDRPLA has been funding research that aims to better understand DRPLA symptoms and how this condition develops over time, such as the DRPLA Natural History and Biomarkers Study. While such research projects are essential for advancing research towards clinical...
This announcement was initially published on our website on February 12, 2024. You can find a pdf version of the announcement here. Dear DRPLA community, Since we established CureDRPLA in 2019, our mission has been to connect families, physicians and scientific...
We have been working with Ataxia UK and the scientific community from around the world to advance research on DRPLA. Our recent article, published in a scientific journal, highlights the strides we and our scientific community have made in understanding DRPLA and our...